Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users

Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations

(2008) Olivier Rascol   ARCHIVES OF NEUROLOGY

The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum

(2008) C.R. Ferrario et al.   BRAIN RESEARCH

Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

(2008) SL McColl et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Assessing Abuse Liability During Drug Development: Changing Standards and Expectations

(2008) KA Schoedel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Abuse liability assessment of atomoxetine in a drug-abusing population

(2008) Donald R. Jasinski et al.   DRUG AND ALCOHOL DEPENDENCE

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

(2008) Arne Astrup et al.   LANCET

Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease

(2008) Arne Astrup et al.   Obesity